Scarica l'app Stockscreener
2.66
3.27%
-0.09
Dopo l'orario di chiusura:
2.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.75
Aprire:
$2.71
Volume 24 ore:
428.54K
Relative Volume:
0.40
Capitalizzazione di mercato:
$246.57M
Reddito:
-
Utile/perdita netta:
$-39.95M
Rapporto P/E:
-5.7217
EPS:
-0.4649
Flusso di cassa netto:
$-34.08M
1 W Prestazione:
-6.67%
1M Prestazione:
-21.53%
6M Prestazione:
-42.67%
1 anno Prestazione:
-70.03%
Intervallo 1D:
$2.615
$2.735
Intervallo di 1 settimana:
$2.615
$2.905
Portata 52W:
$2.255
$10.38
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corp
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.66 | 254.92M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
PVG Asset Management Provides Information to Shareholders of Anavex Life Sciences - marketscreener.com
Six-seat board challenge at Anavex (AVXL) heads to investor call - Stock Titan
PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign - The Manila Times
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 9, 2026) - Stock Titan
Form 8K Anavex Life Sciences Corp For: 10 September By Investing.com - Investing.com India
Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial - Investing.com UK
CRM: Salesforce Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Activist PVG targets Anavex (NASDAQ: AVXL) board, urging investors to back its slate in 2026 - Stock Titan
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET - Anavex Life Sciences
PVG Asset Management Issues Important Information About Anavex Life Sciences - marketscreener.com
PVG Asset Management Pushes for Board Overhaul at Anavex Life Sciences (AVXL) Amid Leadership Concerns - GuruFocus
PVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL) - The Manila Times
Anavex Life Sciences Corp. (AVXL) Latest Stock News & Headlines - Yahoo Finance
A drug developer regains Nasdaq compliance after filing two financial reports - Stock Titan
Anavex Life Sciences (AVXL) Board Shakeup Sparks Pre-Market Inte - GuruFocus
Anavex gains as PVG calls for board reshuffle (AVXL:NASDAQ) - Seeking Alpha
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 3, 2026) - Stock Titan
PVG Asset Management Pushes for Board Changes at Anavex Life Sci - GuruFocus
PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company - GlobeNewswire
PVG Asset Management targets Anavex (NASDAQ: AVXL) board in 2026 vote push - Stock Titan
Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports - marketscreener.com
Anavex Life Sciences regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Anavex Life Sciences regains Nasdaq compliance after filing delayed 10-Qs - TradingView
Anavex Life Sciences regains Nasdaq compliance - Investing.com India
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement - Anavex Life Sciences
Anavex will keep trading on Nasdaq after filing its outstanding reports - Stock Titan
AVXL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
New proxy contest hits Anavex (AVXL) as PVG presses its case for the 2026 shareholder vote - Stock Titan
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting - The Manila Times
PVG Asset Management Corporation Files Definitive Proxy - GlobeNewswire
Anavex Life Sciences : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Anavex (AVXL) admits control weakness yet keeps Dec. 2025 numbers - Stock Titan
Anavex: After The EU Said No, The FDA Path Looks Long And Expensive - Seeking Alpha
Anavex Life Sciences Releases Q3 2026 Financial Results - AlphaStreet
Anavex Life Sciences reports Q3 FY2026 net income $7.8M, cash $118.3M - TradingView
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - king5.com
Anavex (AVXL) Momentum: Moves 7.67% Down to $3.13; Technical Setup: the $2.97 to $3.29 Range Remains in Focus on the DayRetail Volume - Vinanet
PVG mounts six-seat board challenge at Anavex (AVXL) - Stock Titan
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Releases Stockholder Letter and Press Release for 2026 Annual Meeting - Kalkine Media
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com Canada
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - The Manila Times
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex Life Sciences Corp Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):